Lebanon vs Mauritania: Access to anti-retroviral drugs, female
Lebanon
69.0%
in 2024
Mauritania
68.0%
in 2024
Lebanon rank
84th
Mauritania rank
86th
Access to anti-retroviral drugs, female over time
- Lebanon
- Mauritania
How they compare
Lebanon currently reports 69.0% against 68.0% in Mauritania, a difference of 1.0%.
Across all 25 years both countries report, Lebanon has been ahead every year.
Lebanon ranks 84th and Mauritania ranks 86th of 141 countries.
Lebanon has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Lebanon | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.4% | 5.6% | 10.8% | Lebanon |
| 2010s | 42.5% | 35.7% | 6.8% | Lebanon |
| 2020s | 66.8% | 60.4% | 6.4% | Lebanon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Lebanon or Mauritania?
- Lebanon, at 69.0% against 68.0% in Mauritania as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Lebanon and Mauritania?
- 1.0%, with Lebanon ahead.
- How many years of comparable data are there for Lebanon and Mauritania?
- 25 years are reported by both, from 2000 to 2024.
- How do Lebanon and Mauritania rank globally for access to anti-retroviral drugs, female?
- Lebanon ranks 84th and Mauritania ranks 86th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.